Alterity Therapeutics Limited (ATHE) Financials
ATHE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 18.1 million | 3.0 million |
| 2023-03-31 | ? | ? |
ATHE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -3.3 million | ? |
| 2023-09-30 | 350323 | ? |
| 2023-06-30 | -4.1 million | 71185 |
| 2023-03-31 | -2.6 million | 72279 |
ATHE Net Income
No data available :(
ATHE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | - | - | - |
| 2023-06-30 | 10.5 million | - | 139574 |
| 2023-03-31 | - | - | - |
ATHE Shares Outstanding
ATHE Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1362 | - | - | - |
| 2023-09-30 | 2571 | - | - | - |
| 2023-06-30 | 1702 | - | - | - |
| 2023-03-31 | 3355 | - | - | - |
ATHE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | - | - |
| 2023-06-30 | - | - |
| 2023-03-31 | - | - |
ATHE
Price: $2.19
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -1.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8900
Market Capitalization: 23.0 million